ID25660A - Teripatide kristal - Google Patents

Teripatide kristal

Info

Publication number
ID25660A
ID25660A IDW20001360A ID20001360A ID25660A ID 25660 A ID25660 A ID 25660A ID W20001360 A IDW20001360 A ID W20001360A ID 20001360 A ID20001360 A ID 20001360A ID 25660 A ID25660 A ID 25660A
Authority
ID
Indonesia
Prior art keywords
teripatide
crystal
teripatide crystal
Prior art date
Application number
IDW20001360A
Other languages
English (en)
Indonesian (id)
Inventor
Faming Zhang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID25660A publication Critical patent/ID25660A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
IDW20001360A 1997-12-18 1998-12-08 Teripatide kristal ID25660A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6987597P 1997-12-18 1997-12-18

Publications (1)

Publication Number Publication Date
ID25660A true ID25660A (id) 2000-10-19

Family

ID=22091750

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001360A ID25660A (id) 1997-12-18 1998-12-08 Teripatide kristal

Country Status (24)

Country Link
US (1) US6590081B1 (fr)
EP (1) EP0926158B1 (fr)
JP (1) JP2002508395A (fr)
KR (1) KR20010033268A (fr)
CN (1) CN1281467A (fr)
AR (1) AR038648A1 (fr)
AT (1) ATE245165T1 (fr)
AU (1) AU748271B2 (fr)
BR (1) BR9813740A (fr)
CA (1) CA2315103A1 (fr)
DE (1) DE69816409T2 (fr)
DK (1) DK0926158T3 (fr)
EA (1) EA200000672A1 (fr)
ES (1) ES2202729T3 (fr)
HU (1) HUP0100075A2 (fr)
ID (1) ID25660A (fr)
IL (1) IL136824A0 (fr)
NO (1) NO20003131D0 (fr)
PE (1) PE20000056A1 (fr)
PL (1) PL341209A1 (fr)
PT (1) PT926158E (fr)
TR (1) TR200002179T2 (fr)
WO (1) WO1999031137A1 (fr)
ZA (1) ZA9811407B (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601685B2 (en) 1998-08-27 2009-10-13 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
EP1864681A1 (fr) 2001-12-18 2007-12-12 Eidgenössische Technische Hochschule Zürich Matrices de protéines modifiées de facteur de croissance pour ingénierie de tissus
BRPI0215192B8 (pt) * 2001-12-18 2021-07-27 Eidgenoessische Technische Hochschule Zuerich peptídeo de fusão, kit e matriz que compreendem o mesmo, e método para criar uma matriz
US7247609B2 (en) 2001-12-18 2007-07-24 Universitat Zurich Growth factor modified protein matrices for tissue engineering
WO2004022033A1 (fr) * 2002-09-04 2004-03-18 Microchips, Inc. Technique et dispositif d'apport commande d'hormone parathyroide
SG176314A1 (en) 2002-12-31 2011-12-29 Altus Pharmaceuticals Inc Human growth hormone crystals and methods for preparing them
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
US7429378B2 (en) * 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
US7553827B2 (en) * 2003-08-13 2009-06-30 Depuy Spine, Inc. Transdiscal administration of cycline compounds
US20040229878A1 (en) * 2003-05-13 2004-11-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of P38 kinase
US8273347B2 (en) 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US7344716B2 (en) * 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
US8361467B2 (en) * 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
US8895540B2 (en) * 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
US20060052305A1 (en) * 2004-05-10 2006-03-09 Nastech Pharmaceutical Company Inc. Method of treating osteoporosis using intranasal parathyroid hormone
US20060127320A1 (en) * 2004-05-10 2006-06-15 Nastech Pharmaceutical Company Inc. Method of delivering parathyroid hormone to a human
US7244709B2 (en) * 2004-05-10 2007-07-17 Nastech Pharamecutical Company Inc. Compositions and methods for enhanced mucosal delivery of parathyroid hormone
AU2005244734A1 (en) 2004-05-13 2005-12-01 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
WO2006073711A2 (fr) 2005-01-06 2006-07-13 Kuros Biosurgery Ag Traitement local des deficits osseux
US8575101B2 (en) 2005-01-06 2013-11-05 Kuros Biosurgery Ag Supplemented matrices for the repair of bone fractures
US7691105B2 (en) 2005-09-26 2010-04-06 Depuy Spine, Inc. Tissue augmentation, stabilization and regeneration technique
US20070088436A1 (en) * 2005-09-29 2007-04-19 Matthew Parsons Methods and devices for stenting or tamping a fractured vertebral body
US20070173447A1 (en) * 2005-10-25 2007-07-26 Nastech Pharmaceutical Company Inc. Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent
WO2007059470A2 (fr) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Parathormone de l'ours noir et procedes d'utilisation de la parathormone de l'ours noir
US20080051332A1 (en) * 2005-11-18 2008-02-28 Nastech Pharmaceutical Company Inc. Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
US20070168041A1 (en) * 2006-01-17 2007-07-19 Sudhakar Kadiyala Method and instruments for intervertebral disc augmentation through a pedicular approach
CN101711168B (zh) 2007-04-13 2013-05-01 库罗斯生物外科股份公司 聚合物组织封闭剂
EP2173768B1 (fr) * 2007-08-09 2014-03-05 USV Limited Nouveau procédé orthogonal pour la purification de l'hormone parathyroïdienne humaine recombinante (rhpth) (1-34)
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
US8241363B2 (en) 2007-12-19 2012-08-14 Depuy Spine, Inc. Expandable corpectomy spinal fusion cage
US8241294B2 (en) 2007-12-19 2012-08-14 Depuy Spine, Inc. Instruments for expandable corpectomy spinal fusion cage
US8986696B2 (en) * 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
US20090162351A1 (en) * 2007-12-21 2009-06-25 Depuy Spine, Inc. Transdiscal administration of inhibitors of p38 MAP kinase
WO2009083544A2 (fr) 2007-12-28 2009-07-09 Kuros Biosurgery Ag Protéines hybrides du pdgf incorporées dans des mousses de fibrine
US8876905B2 (en) 2009-04-29 2014-11-04 DePuy Synthes Products, LLC Minimally invasive corpectomy cage and instrument
JP2013512688A (ja) 2009-12-07 2013-04-18 ミシガン テクノロジカル ユニバーシティ クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法
US8865220B2 (en) 2010-06-14 2014-10-21 Kaohsiung Medical University Method for controlled release of parathyroid hormone from encapsulated poly(lactic-glycolic)acid microspheres
WO2012123028A1 (fr) 2011-03-16 2012-09-20 Kuros Biosurgery Ag Formulation pharmaceutique destinée à être utilisée dans une fusion des vertèbres
CN102731643A (zh) * 2012-06-26 2012-10-17 深圳翰宇药业股份有限公司 一种治疗骨质疏松多肽的制备方法
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
CN104910269B (zh) * 2015-06-02 2018-08-17 成都圣诺生物科技股份有限公司 一种合成特立帕肽的方法
JP6577683B2 (ja) * 2017-09-22 2019-09-18 旭化成ファーマ株式会社 安定性に優れるテリパラチド含有液状医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62106000A (ja) 1985-10-30 1987-05-16 Fujitsu Ltd 生体高分子結晶自動作製装置
EP0415924B1 (fr) * 1987-10-20 1996-05-29 HOLICK, Michael F Regulation de la proliferation et de la differenciation cellulaires par utilisation de peptides
MX9205727A (es) 1991-10-09 1993-04-01 Schering Corp Dispositivo para la formacion de cristales y sistema automatizado de cristalizacion
US5400741A (en) * 1993-05-21 1995-03-28 Medical Foundation Of Buffalo, Inc. Device for growing crystals
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
US5419278A (en) * 1994-05-25 1995-05-30 Carter; Daniel C. Vapor equilibration tray for growing protein crystals
CA2178894A1 (fr) 1995-06-15 1996-12-16 Tsunehiko Fukuda Derives de la parathormone et leur utilisation

Also Published As

Publication number Publication date
TR200002179T2 (tr) 2001-07-23
AR038648A1 (es) 2005-01-26
EP0926158B1 (fr) 2003-07-16
NO20003131L (no) 2000-06-16
EA200000672A1 (ru) 2000-12-25
DE69816409T2 (de) 2004-06-09
ES2202729T3 (es) 2004-04-01
PT926158E (pt) 2003-11-28
BR9813740A (pt) 2000-10-10
NO20003131D0 (no) 2000-06-16
AU748271B2 (en) 2002-05-30
DE69816409D1 (de) 2003-08-21
EP0926158A1 (fr) 1999-06-30
IL136824A0 (en) 2001-06-14
KR20010033268A (ko) 2001-04-25
WO1999031137A1 (fr) 1999-06-24
JP2002508395A (ja) 2002-03-19
HUP0100075A2 (hu) 2001-05-28
AU1632699A (en) 1999-07-05
CA2315103A1 (fr) 1999-06-24
DK0926158T3 (da) 2003-11-10
PE20000056A1 (es) 2000-02-08
US6590081B1 (en) 2003-07-08
ATE245165T1 (de) 2003-08-15
CN1281467A (zh) 2001-01-24
PL341209A1 (en) 2001-03-26
ZA9811407B (en) 2000-07-13

Similar Documents

Publication Publication Date Title
ID25660A (id) Teripatide kristal
ID25534A (id) Glucagon-seperti kristal peptida-1
DE69822774D1 (de) Armbanduhr
DE69839157D1 (de) Fullurene enthaltendes katherdersystem
PT1021439E (pt) Polimorfo antifungico cristalino
DE69837796D1 (de) Flüssigkristallanzeige
DE59810372D1 (de) Stativ
DE69839563D1 (de) Kohlenhydrat-vernetzte glykoproteinkristalle
ID19914A (id) Kacamata
TR199801513A3 (tr) N-(4-Triflormetilfenil)- 5- metil-izoksazol-4-karboksamidin kristal formu.
KR970705775A (ko) 강유전성 액정 장치(Ferroeletric loquid crystal devices)
DE69622942T2 (de) Flussigkristall-anzeigvorrichtung
DE69531247D1 (de) Orientierte kristallanordnung
DE69612725T2 (de) Kristallhaltevorrichtung
DE69800559D1 (de) Ferrielektrische Flüssigkristallverbindung
DE69801549D1 (de) Schwalbenschwanzförmige Flüssigkristallverbindung
DE69710146T2 (de) Kristallhaltevorrichtung
DE69823908D1 (de) Einkristallziehvorrichtung
NO970910D0 (no) Spirostanylglykosidal-krystaller
IT1292010B1 (it) Ganasce per cristallo
DE69508469D1 (de) Oxyde-Granat-Einkristall
ID27596A (id) Bentuk paroksetina kristal
DE69920662D1 (de) Sibe-kristall
DE69734891D1 (de) Ausrichtvorrichtung
ATA195097A (de) Korbartiger baustein